SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
This Quarter Return
-40.93%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$94.6M
AUM Growth
+$94.6M
Cap. Flow
+$15.6M
Cap. Flow %
16.49%
Top 10 Hldgs %
59.92%
Holding
33
New
10
Increased
8
Reduced
8
Closed
7

Top Buys

1
LGND icon
Ligand Pharmaceuticals
LGND
$11.7M
2
STML
Stemline Therapeutics, Inc.
STML
$4.29M
3
CDTX icon
Cidara Therapeutics
CDTX
$3.23M
4
GYRE icon
Gyre Therapeutics
GYRE
$3.11M
5
BDSI
BioDelivery Sciences International, Inc.
BDSI
$2.86M

Top Sells

1
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
$3.97M
2
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
$3.12M
3
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
$2.76M
4
APVO icon
Aptevo Therapeutics
APVO
$2.73M
5
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.37M

Sector Composition

1 Healthcare 91.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$3.15B
$11.7M 12.38% +160,919 New +$11.7M
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.89M 9.4% 2,583,786 -416,214 -14% -$1.43M
CTIC
3
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5.92M 6.26% 6,430,637 +2,675,637 +71% +$2.46M
AMRN
4
Amarin Corp
AMRN
$311M
$5.25M 5.55% 1,313,100 -238,200 -15% -$953K
AFMD
5
DELISTED
Affimed
AFMD
$4.74M 5.01% 3,000,000 -1,010,155 -25% -$1.6M
GYRE icon
6
Gyre Therapeutics
GYRE
$703M
$4.45M 4.71% 1,019,196 +711,909 +232% +$3.11M
STML
7
DELISTED
Stemline Therapeutics, Inc.
STML
$4.29M 4.54% +886,632 New +$4.29M
XOMA icon
8
Xoma
XOMA
$392M
$4.25M 4.49% 208,600 +7,933 +4% +$161K
OPNT
9
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$3.65M 3.86% 380,948 +46,676 +14% +$447K
NEOS
10
DELISTED
Neos Therapeutics, Inc
NEOS
$3.52M 3.72% 4,690,146 -168,743 -3% -$127K
OXFD
11
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.47M 3.67% 374,431 -256,431 -41% -$2.37M
EOLS icon
12
Evolus
EOLS
$494M
$3.42M 3.61% 822,960 +428,070 +108% +$1.78M
ADMS
13
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$3.36M 3.55% 1,162,876 -1,078,363 -48% -$3.12M
CPIX icon
14
Cumberland Pharmaceuticals
CPIX
$52.2M
$3.3M 3.48% 907,735 +11,565 +1% +$42K
APEN
15
DELISTED
Apollo Endosurgery, Inc.
APEN
$3.23M 3.42% 1,683,861 +32,528 +2% +$62.5K
CDTX icon
16
Cidara Therapeutics
CDTX
$1.66B
$3.23M 3.42% +1,302,981 New +$3.23M
BDSI
17
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2.86M 3.03% +755,000 New +$2.86M
CHMA
18
DELISTED
Chiasma, Inc. Common Stock
CHMA
$2.72M 2.87% 744,134 +560,474 +305% +$2.05M
DMAC icon
19
DiaMedica Therapeutics
DMAC
$295M
$2.31M 2.44% +825,297 New +$2.31M
SPNE
20
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$2.07M 2.19% +253,131 New +$2.07M
AGTC
21
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.93M 2.04% +586,969 New +$1.93M
BXRX
22
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$1.51M 1.6% +610,200 New +$1.51M
IDXG
23
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$924K 0.98% 178,295 -765,556 -81% -$3.97M
ATRS
24
DELISTED
Antares Pharma, Inc.
ATRS
$357K 0.38% +151,189 New +$357K
HTGM
25
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$323K 0.34% 992,641 -3,765,785 -79% -$1.23M
1
2